CN106138686A - 一种治疗早期瘿瘤的中药制剂 - Google Patents
一种治疗早期瘿瘤的中药制剂 Download PDFInfo
- Publication number
- CN106138686A CN106138686A CN201510180348.8A CN201510180348A CN106138686A CN 106138686 A CN106138686 A CN 106138686A CN 201510180348 A CN201510180348 A CN 201510180348A CN 106138686 A CN106138686 A CN 106138686A
- Authority
- CN
- China
- Prior art keywords
- parts
- root
- radix
- chinese medicine
- tuber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 35
- 206010018498 Goitre Diseases 0.000 title claims abstract description 19
- 201000003872 goiter Diseases 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 15
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 9
- 235000008113 selfheal Nutrition 0.000 claims abstract description 9
- 240000005717 Dioscorea alata Species 0.000 claims abstract description 8
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 8
- 241001412627 Adenophora liliifolia Species 0.000 claims abstract description 7
- 241000132012 Atractylodes Species 0.000 claims abstract description 7
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 7
- 240000002948 Ophiopogon intermedius Species 0.000 claims abstract description 7
- 241001522129 Pinellia Species 0.000 claims abstract description 7
- 239000009636 Huang Qi Substances 0.000 claims abstract description 6
- 239000000843 powder Substances 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 244000170916 Paeonia officinalis Species 0.000 claims abstract 3
- 206010028980 Neoplasm Diseases 0.000 claims description 14
- 244000131316 Panax pseudoginseng Species 0.000 claims description 7
- 240000004307 Citrus medica Species 0.000 claims description 6
- 241000112528 Ligusticum striatum Species 0.000 claims description 6
- 244000241872 Lycium chinense Species 0.000 claims description 6
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 6
- 244000197580 Poria cocos Species 0.000 claims description 6
- 235000008599 Poria cocos Nutrition 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 238000011282 treatment Methods 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 14
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 210000004185 liver Anatomy 0.000 abstract description 8
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 5
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 238000011084 recovery Methods 0.000 abstract description 3
- 241000405414 Rehmannia Species 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000236521 Bupleurum rotundifolium Species 0.000 abstract 1
- 235000015221 Bupleurum rotundifolium Nutrition 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 239000009759 San-Chi Substances 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 235000021419 vinegar Nutrition 0.000 abstract 1
- 239000000052 vinegar Substances 0.000 abstract 1
- 210000001685 thyroid gland Anatomy 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 241000736199 Paeonia Species 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 208000019505 Deglutition disease Diseases 0.000 description 4
- 206010013952 Dysphonia Diseases 0.000 description 4
- 208000010473 Hoarseness Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 230000002146 bilateral effect Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 208000017574 dry cough Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 241001582888 Lobus Species 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 206010042772 syncope Diseases 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000002386 leaching Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- UYALWPKCIMKALF-YHPVUIEZSA-N (1S,3R,5S,6R,8R,10R,11S,12S)-3-(furan-3-yl)-8-hydroxy-5-methyl-14-oxo-2,13-dioxatetracyclo[10.2.1.01,5.06,11]pentadecane-10-carboxylic acid Chemical compound C[C@@]12C[C@@H](O[C@@]11C[C@H](OC1=O)[C@@H]1[C@@H](C[C@H](O)C[C@@H]21)C(O)=O)c1ccoc1 UYALWPKCIMKALF-YHPVUIEZSA-N 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- QEANLIISUSNNDX-YHPVUIEZSA-N Diosbulbin B Chemical compound C=1([C@H]2C[C@@]3([C@@]4(C(O[C@@H](C4)[C@H]4[C@H]3C[C@@H]3C[C@H]4C(O3)=O)=O)O2)C)C=COC=1 QEANLIISUSNNDX-YHPVUIEZSA-N 0.000 description 1
- UYALWPKCIMKALF-UHFFFAOYSA-N Diosbulbin C Natural products O1C2(C(OC(C2)C2C3CC(O)CC2C(O)=O)=O)C3(C)CC1C=1C=COC=1 UYALWPKCIMKALF-UHFFFAOYSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010067997 Iodine deficiency Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010043706 Thyroid cyst Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 229940124579 cold medicine Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- QEANLIISUSNNDX-UHFFFAOYSA-N diosbulbin B Natural products O1C2(C(OC(C2)C2C3CC4CC2C(O4)=O)=O)C3(C)CC1C=1C=COC=1 QEANLIISUSNNDX-UHFFFAOYSA-N 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000013210 hematogenous Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000002425 internal capsule Anatomy 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 235000006479 iodine deficiency Nutrition 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 201000008494 nodular goiter Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 206010043688 thyroid adenoma Diseases 0.000 description 1
- 206010043778 thyroiditis Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗早期瘿瘤的中药制剂,其特征在于:它是由下列重量配比的优选原料药物的组分组成:黄药子、夏枯草、白芍、柴胡、山茱萸、川芎、半夏、香附、陈皮(醋炒)、生地黄、枸杞子、枳实(麸炒)份、沙参、麦冬、当归、川楝子、黄芪、白术、茯苓、三七(粉)份、甘草(炙)等。本发明药物具有疏肝理气、化瘀散结、清热养阴、软坚散结、活血化瘀等功效,对早期瘿瘤患者治疗彻底,疗效好,无毒副作用,患者康复快,不易复发,而且治疗周期短,费用低,所选用中药原料药源丰富,便于推广应用。
Description
技术领域
本发明属于中药技术领域,尤其是涉及一种治疗早期瘿瘤的中药制剂。
背景技术
瘿瘤是一种多发常见病之一,是指人体颈部的囊肿或肿块,初起没有典型症状,以后头颈逐渐变粗,患者乏力颈部不适,有时出现干咳,声音嘶哑,吞咽困难,影响工作与睡眠。早期病程较短或为一过性,其主要病机为肝郁气滞,血行不畅,瘀热伤阴。瘿瘤主要包括甲状腺结、节,单纯性甲状腺肿、结节性甲状腺肿、甲状腺囊肿、甲状腺腺瘤等。近年来,本病的发病率和诊断率不断攀升。甲状腺肿疾病严重时会压迫周围器官,容易引起饮食和呼吸困难。目前,常常采用手术治疗,然而手术后往往会出现甲状腺功能的衰退,甚至会留下永久的疤痕。西医治疗多用甲状腺素片或口服碘化钾等药物对症治疗可缓解症状,但不能根治,易复发,疗效慢、疗程长,效果不明显。
发明内容
为了克服上述技术问题的不足,本发明提供一种治疗早期瘿瘤的中药制剂。
其技术解决方案是:
一种治疗早期瘿瘤的中药制剂,其特征在于:由下述重量配比的原料制成:
黄药子3-9份、夏枯草10-20份、白芍3-12份、柴胡3-10份、
山茱萸6-15份、川芎3-10份、半夏3-15份、香附3-9份、
陈皮(醋炒)3-12份、生地黄15-35份、枸杞子15-30份、枳实(麸炒)10-30份、
沙参6-15份、麦冬6-15份、当归6-15份、川楝子3-6份、
黄芪9-15份、白术6-15份、茯苓6-15份、三七(粉)10-20份、
甘草(炙)3-6份。
一种治疗早期瘿瘤的中药制剂,优选由以下重量份的中药原料制作而成的:
黄药子6份、夏枯草15份、白芍6份、柴胡6份、
山茱萸9份、川芎6份、半夏9份、香附6份、
陈皮(醋炒)6份、生地黄30份、枸杞子18份、枳实(麸炒)20份、
沙参9份、麦冬9份、当归9份、川楝子3份、
黄芪12份、白术10份、茯苓10份、三七(粉)15份、
甘草(炙)3份。
本发明的药理及效果如下:
所选中药原料,黄药子:含有黄独萜酯A(diosbulbine A)、皂甙、鞣质和淀粉。半干燥块茎含蔗糖22.5%、还原糖0.69%、淀粉2.5%、皂甙、鞣质。还含黄独素B,C 与薯蓣皂甙元。【性味归经】苦、辛,凉。有小毒。【功能主治】解毒消肿,化痰散结,凉血止血。用于甲状腺肿大,淋巴结结核,咽喉肿痛,吐血,咯血,百日咳,癌肿;外用治疮疖。药理作用:黄药子对缺碘所致的动物甲状腺肿有一定的治疗作用。水煎剂或醇浸物水液对离体肠管有抑制作用,而对未孕子宫则有兴奋作用,此外有止血作用。水浸剂体外对多种致病真菌有不同程度的抑制作用。能直接抑制心肌,醇浸物水液的抑制作用较水煎剂强。
夏枯草:《纲目》:楼全善云,夏枯草治目珠疼至夜则甚者,神效,或用苦寒药点之反甚者,亦神效。盖目珠连目本,肝系也,属厥阴之经。夜甚及点苦寒药反甚者,夜与寒亦阴故也。夏枯禀纯阳之气,补厥阴血脉,故治此如神,以阳治阴也。《本草通玄》:夏枯草,补养厥阴血脉,又能疏通结气。目痛、瘰疬皆系肝症,故建神功。然久用亦防伤胃,与参、术同行,方可久服无弊。
方中白芍养肝敛阴,和胃止痛,与柴胡相伍一散一收,助柴胡疏肝,相反相成共为主药;配枳实泻脾气之壅滞,调中焦之运动与柴胡同用一升一降,加强疏肝理气之功,以达郁邪;白芍、甘草配伍缓急止痛,疏理肝气以和脾胃,且具有保护胃粘膜屏障和修复粘膜之作用;川芎行气开郁,活血止痛;半夏是因为其性味辛,温,有毒,入脾、胃经,有燥湿化痰,降逆止呕,消痞散结的功能,治湿痰冷饮,呕吐,反胃,咳喘痰多,胸膈胀满,痰厥头痛,头晕不眠,外消痈肿;香附、陈皮理气和胃止痛,且有助于消除上腹痛不适等症。诸药合用辛以散结,苦以降通,气滞郁结方可解除。重用生地滋阴养血以补肝肾为君;沙参、麦冬、当归、枸杞子配合君药滋阴养血生津以柔肝为臣;更用少量川楝子疏泄肝气为佐、使。共奏滋阴疏肝之功。白术,其性味苦甘,温,入脾、胃经,有补脾,益胃,燥湿,和中的功能;用茯苓是因为其性味甘淡,平,入心、脾、肺经,有渗湿利水,益脾和胃,宁心安神的功能;三七,活血化瘀,软坚散结。
本发明药物用法与用量:水煎服,每日一剂,剂量为300 ~ 500 毫升。
有益效果
本发明药物具有疏肝理气、化瘀散结、清热养阴、软坚散结、活血化瘀等功效,对早期瘿瘤患者治疗彻底,疗效好,无毒副作用,患者康复快,不易复发,而且治疗周期短,费用低,所选用中药原料药源丰富,便于推广应用。
具体实施方式
实施例:一种治疗早期瘿瘤的中药制剂,优选由以下重量份的中药原料制作而成的:
黄药子6g、夏枯草15g、白芍6g、柴胡6g、
山茱萸9g、川芎6g、半夏9g、香附6g、
陈皮(醋炒)6g、生地黄30g、枸杞子18g、枳实(麸炒)20g、
沙参9g、麦冬9g、当归9g、川楝子3g、
黄芪12g、白术10g、茯苓10g、三七(粉)15g、
甘草(炙)3g。每日一剂,剂量为300毫升,每日口服两次,早晚各一次,常规煎药方式煎服,十五天为一疗程。
临床资料
1、动物毒性试验资料
取西德兔20 只,雌雄兼用,体重2—2.5kg,分两组,每组10 只,其中一组为超剂量试验组,二组为正常量试验组,超剂量组为30ml/kg,正常量为10ml/kg,给药方式为灌胃法给药,每天两次,连服七天,每天观察给药反应,结果表明二组家兔活动饮食正常,。
2、一般治疗
收治门诊患者200 例,随机将患者分为两组,治疗组100 例,给予本发明药物治疗,对照组100 例,给予现有药物左旋甲状腺素治疗;治疗组中40 岁以下18 例,40-49 岁38 例,50-59 岁27 例,60 岁以上17 例;对照组中40 岁以下19 例,40-49 岁40 例,50-59 岁22 例,60 岁以上19 例;两组患者在平均年龄、病程、病情方面,基本平衡,具有可比性。
、诊断标准
患病初期,病人感觉精神不好,颈部不适,食欲减退,纳差,有时干咳,声音嘶哑,以
后颈部逐步变粗,吞咽困难。
、治疗方法
治疗方法是在病人自愿前提下,治疗组患者服用本发明药物汤剂,每日一剂,剂量为300 毫升,每日口服两次,早晚各一次,按照上述煎药方式煎服,十五天为一疗程,连服三个疗
程。对照组患者仍采用现有药物左旋甲状腺素进行长期治疗。
5、疗效评定标准(以临床症状消失为准)
显效:患者精神、饮食恢复正常,观察一年无复发者;
好转:患者精神及饮食恢复正常,颈部逐渐消肿恢复正常;
无效:达不到好转标准者。
6、结果与分析
表1
从表1 中可以看出,治疗组疗效明显优于对照组。在三个疗程中,用本发明药物治疗甲状腺肿大患者100例,结果总有效率为97%。
典型病例
病例一:李某,女29 岁,感觉精神不好,颈部不适,食欲减退,纳差,有时干咳,声音嘶哑,以后颈部逐步变粗,吞咽困难。2012 年4 月去医院查身体,超声所见:甲状腺左叶大小形态正常,右叶体积增大,形态饱满,腺体回声分布尚均匀,双叶见数个结节回声,左叶较大的位于中下部前侧,大小约7 x 5
mm,边界尚清,形状规则,呈实质性略低回声,内部回声不均,CDFI :结节内及边缘见点状血流信号。右叶较大的位于中部,大小约22 x 14 mm,边界清,形状规则,呈以囊性为主的混合性,内部回声不均,CDFI :血流信号不明显。颈部扫查:双侧颌下及双侧颈部见多个小淋巴结回声,边界清,内部结构未见明显异常。使用本发明实施例三个月后,手摸感觉结节消失,去医院超声波检查甲状腺一切正常。
病例二,赵XX,女,28 岁,感觉精神不好,颈部不适,食欲减退,纳差,有时干咳,声音嘶哑,以后颈部逐步变粗,吞咽困难;2010 年6 月8 日医院检查化验确诊为瘿瘤(甲状腺炎、甲状腺肿),西药治疗3 个多月疗效不显著,服用本发明中药制剂,药后45 天血检各项指标基本正常,95 天后痊愈。
病例三:李某:女,35 岁,工人。2008 年6 月就诊。甲状腺肿大1 年多,时有咽部堵塞感。B 超检查:双侧甲状腺呈中度均匀肿大,约5cm×3cm×2cm,内见有斑状强回声,质欠均,峡部略见增宽。诊断:瘿瘤(双侧甲状腺肿大)。给予本发明中药制剂,服用2疗程,症状明显减轻,继服4 疗程,诸症消失痊愈,随访至今未再复发。
Claims (2)
1.一种治疗早期瘿瘤的中药制剂,其特征在于由下述重量配比的原料制成:
黄药子3-9份、夏枯草10-20份、白芍3-12份、柴胡3-10份、
山茱萸6-15份、川芎3-10份、半夏3-15份、香附3-9份、
陈皮(醋炒)3-12份、生地黄15-35份、枸杞子15-30份、枳实(麸炒)10-30份、
沙参6-15份、麦冬6-15份、当归6-15份、川楝子3-6份、
黄芪9-15份、白术6-15份、茯苓6-15份、三七(粉)10-20份、
甘草(炙)3-6份。
2.根据权利要求1 所述的一种治疗早期瘿瘤的中药制剂,其特征是优选由以下重量份的中药原料制作而成的:黄药子6份、夏枯草15份、白芍6份、柴胡6份、
山茱萸9份、川芎6份、半夏9份、香附6份、
陈皮(醋炒)6份、生地黄30份、枸杞子18份、枳实(麸炒)20份、
沙参9份、麦冬9份、当归9份、川楝子3份、
黄芪12份、白术10份、茯苓10份、三七(粉)15份、
甘草(炙)3份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510180348.8A CN106138686A (zh) | 2015-04-16 | 2015-04-16 | 一种治疗早期瘿瘤的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510180348.8A CN106138686A (zh) | 2015-04-16 | 2015-04-16 | 一种治疗早期瘿瘤的中药制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106138686A true CN106138686A (zh) | 2016-11-23 |
Family
ID=58057462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510180348.8A Pending CN106138686A (zh) | 2015-04-16 | 2015-04-16 | 一种治疗早期瘿瘤的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106138686A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112972637A (zh) * | 2021-04-06 | 2021-06-18 | 徐州医科大学 | 一种中药散结足浴包、制备方法及其使用方法 |
-
2015
- 2015-04-16 CN CN201510180348.8A patent/CN106138686A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112972637A (zh) * | 2021-04-06 | 2021-06-18 | 徐州医科大学 | 一种中药散结足浴包、制备方法及其使用方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105535694A (zh) | 一种治疗高尿酸血症的中药组合物 | |
CN104225441A (zh) | 一种治疗胃病的中药组合物及其颗粒剂和胶囊剂的制备方法 | |
CN103520395A (zh) | 一种治疗肺癌的中药组合物 | |
CN103550506B (zh) | 一种用于放疗中配合使用的中药组合物 | |
CN105169212A (zh) | 一种用于治疗慢性胃炎的中药组合物 | |
CN104001035A (zh) | 一种治疗二型糖尿病花粉葛根中药制剂 | |
CN104873705A (zh) | 一种治疗冠心病心绞痛的药物组合物及其应用 | |
CN102526498A (zh) | 治疗鼻咽癌放疗后毒副作用的中药、制备方法及给药方式 | |
CN102988887A (zh) | 一种治疗卵巢囊肿的中药 | |
CN106138668A (zh) | 一种治疗慢性阻塞性肺疾病的中药组合物及其制备方法 | |
CN106138983A (zh) | 一种治疗中期瘿瘤的中药制剂 | |
CN102614474A (zh) | 用于治疗冠心病的中药及其制备方法 | |
CN103393986B (zh) | 一种治疗乙肝肝硬化的中药组合物及其制备方法 | |
CN103285343B (zh) | 一种治疗肝癌的药物及其制备方法 | |
CN106138686A (zh) | 一种治疗早期瘿瘤的中药制剂 | |
CN102935214B (zh) | 一种治疗尿毒症的中药组合物 | |
CN105106634A (zh) | 一种治疗急性阑尾炎的中药制剂及其应用 | |
CN103494939A (zh) | 一种治疗老年习惯性便秘的中药 | |
CN104740465A (zh) | 一种治疗过敏性鼻炎的中药组合物 | |
CN104998158A (zh) | 一种治疗肝硬化的药物组合物及其应用 | |
CN104623605A (zh) | 治疗乳腺癌的中药 | |
CN103285130B (zh) | 治疗肝癌的中药组合物及其制备方法 | |
CN101693096A (zh) | 一种治疗肝癌的药物及其制备方法 | |
CN103212033B (zh) | 一种治疗病毒性肝炎的药物组合物 | |
CN110613830B (zh) | 一种用于治疗慢性阻塞性肺疾病的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161123 |